Based on the Danaher Corporation stock forecast from 0 analysts, the average analyst target price for Danaher Corporation is not available over the next 12 months. Danaher Corporation’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Danaher Corporation is Neutral, which is based on 7 positive signals and 7 negative signals. At the last closing, Danaher Corporation’s stock price was EUR 245.60. Danaher Corporation’s stock price has changed by +1.01% over the past week, -0.49% over the past month and +3.54% over the last year.
No recent analyst target price found for Danaher Corporation
No recent average analyst rating found for Danaher Corporation
Company Overview Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a research collaboration with Stanford University's Department of Bioengineering for cancer drug development. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia. Read Less
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development a...Read More
Frequently Asked Questions About Danaher Corporation (DAP:F) Stock
Stock Target Advisor's fundamental analysis for Danaher Corporation's stock is Neutral.
DAP:F stock's dividend yield is 0.40%.
Our analysis grades DAP:F stock's dividend yield at F. This means that DAP:F stock's dividend yield is above 13% of the stocks in the Diagnostics & Research sector in the F exchange.
Based on this DAP:F may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on DAP:F's stock to indicate what its average analyst target is.
DAP:F stock's Price/Earning ratio is 50.49.
Our analysis grades DAP:F stock's Price / Earning ratio at F. This means that DAP:F stock's Price/Earning ratio is above 73% of the stocks in the Diagnostics & Research sector in the F exchange.
Based on this DAP:F may be a overvalued for its sector.
The last closing price of DAP:F's stock was EUR 245.60.
The most recent market capitalization for DAP:F is EUR 180.49B.
Unfortunately we do not have enough analyst data on DAP:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Danaher Corporation's stock.
As per our most recent records Danaher Corporation has 61,000 Employees.
Danaher Corporation's registered address is 2200 Pennsylvania Avenue, North West, Washington, DC, United States, 20037-1701.
You can get more information about it from Danaher Corporation's website at https://www.danaher.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
High dividend returns
The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Danaher Corporation (DAP:F) Stock
Stock Target Advisor's fundamental analysis for Danaher Corporation's stock is Neutral.
DAP:F stock's dividend yield is 0.40%.
Our analysis grades DAP:F stock's dividend yield at F. This means that DAP:F stock's dividend yield is above 13% of the stocks in the Diagnostics & Research sector in the F exchange.
Based on this DAP:F may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on DAP:F's stock to indicate what its average analyst target is.
DAP:F stock's Price/Earning ratio is 50.49.
Our analysis grades DAP:F stock's Price / Earning ratio at F. This means that DAP:F stock's Price/Earning ratio is above 73% of the stocks in the Diagnostics & Research sector in the F exchange.
Based on this DAP:F may be a overvalued for its sector.
The last closing price of DAP:F's stock was EUR 245.60.
The most recent market capitalization for DAP:F is EUR 180.49B.
Unfortunately we do not have enough analyst data on DAP:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Danaher Corporation's stock.
As per our most recent records Danaher Corporation has 61,000 Employees.
Danaher Corporation's registered address is 2200 Pennsylvania Avenue, North West, Washington, DC, United States, 20037-1701.
You can get more information about it from Danaher Corporation's website at https://www.danaher.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for DAP:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
